The abstract reveals FUS has a chaperone-like function regulating TAZ condensate dynamics, but doesn't address how FUS mutations in ALS/FTD might disrupt this function. This gap is critical since FUS mutations cause neurodegeneration, yet this newly discovered role in transcriptional regulation remains unexplored in disease context. Gap type: open_question Source paper: A chaperone-like function of FUS ensures TAZ condensate dynamics and transcriptional activation. (None, None, PMID:38172614)
Landscape Summary: How does FUS loss-of-function in TAZ regulation contribute to ALS/FTD pathogenesis? is a 0.89 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: partially_addressed.
Colonna, Sevlever, et al. (TREM2 biology)
How does FUS loss-of-function in TAZ regulation contribute to ALS/FTD pathogenesis? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: